Depsidones could have the potential as lead metabolites for neurodegenerative illnesses and diabetes through their inhibition of butyrylcholinesterase, tyrosinase, α-glucosidase, and acetylcholinesterase enzymes. This evidence concerns the gene TYR and diabetes mellitus.